Takeda, a global pharmaceutical leader, is celebrating a decade in Vietnam, emphasizing its commitment to improving ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...

A Senate hearing Tuesday will look at why the list prices of Ozempic and Wegovy are much higher in the U.S. than in ...

Proposed European pharmaceutical reforms aim to tackle, amongst others, healthcare access inequalities amongst Member States.

Presented by MedTech Europe By CLAUDIA CHIAPPA with MARI ECCLES, GIEDRE PESECKYTE and RORY O’NEILL PRESENTED BY View in your ...

Donald Trump is looking to attract firms invested overseas back to the US but could face a stern test in doing so with the ...

For the first time since 2009, the Top 100 Private Companies List's combined revenue declined. And one struggling industry at ...

VIR plans to host a healthcare conference on September 25, expecting to attract about 200 participants, including ...

The head of the Drug Enforcement Administration says that the drug industry bears a lot of the blame for starting the ...

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business following a similar trajectory.